Pneumococcal Vaccine
Sponsors
National Institute on Aging (NIA), M.D. Anderson Cancer Center, GlaxoSmithKline, Novartis Vaccines, National Cancer Institute (NCI)
Conditions
AgingAutoimmune Rheumatic DiseasesAutoimmune Rheumatologic DiseaseBladder CancerBreast CancerCOPDColon CancerCoronavirus
Phase 1
Phase 2
Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients
CompletedNCT00323557
Start: 2004-06-30End: 2011-05-31Updated: 2012-12-05
Safety and Immune Response Study of an Investigational Pneumococcal Vaccine.
CompletedNCT00327522
Start: 2006-06-30Target: 10Updated: 2008-10-13
Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules
CompletedNCT00721396
Start: 2008-08-31End: 2010-07-31Updated: 2015-03-23
Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy
TerminatedNCT01339000
Start: 2011-04-30End: 2016-04-30Updated: 2016-06-22
A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19
CompletedNCT04515147
Start: 2020-09-21End: 2022-02-21Updated: 2023-09-28
A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants
RecruitingNCT06213506
Start: 2024-01-15End: 2026-04-27Target: 516Updated: 2024-01-19
Phase 3
Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines.
CompletedNCT00333450
Start: 2006-08-31End: 2006-12-31Target: 120Updated: 2016-10-07
Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers
CompletedNCT01411241
Start: 2011-07-18End: 2014-04-30Updated: 2022-03-25
Phase 4
PPV: Pneumococcal Polysaccharide Vaccine in Older Adults
CompletedNCT00239694
Start: 2001-04-30End: 2012-08-31Updated: 2015-08-04
Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines
Not yet recruitingNCT07135453
Start: 2026-03-01End: 2027-08-01Target: 70Updated: 2026-03-13
Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs
Not yet recruitingNCT07242092
Start: 2026-03-25End: 2028-12-30Target: 192Updated: 2026-03-24
Safety and Immunogenicity of PCV20 in Pediatric Patients With Autoimmune Rheumatic Diseases
RecruitingNCT07252791
Start: 2026-01-16End: 2027-12-30Target: 114Updated: 2026-03-04
Unknown Phase
Pneumococcal Vaccination in Patients with Anti-TNF Alpha Therapy
CompletedNCT05788510
Start: 2023-04-03End: 2023-05-06Updated: 2024-09-19
Fine Needle aSpiration of Lymph nodEs to Study vAccine-induced Immunity
RecruitingNCT06202703
Start: 2023-04-15End: 2024-10-15Target: 5Updated: 2024-01-11
Structured Review: To Optimise Management and Prevent Harm in COPD
Not yet recruitingNCT07460154
Start: 2026-03-01End: 2029-03-02Target: 96Updated: 2026-03-10